Validity and Characterization of Time to Symptom Resolution Outcome Measures in the ACTIV-2/A5401 Outpatient COVID-19 Treatment Trial.

Kara W. Chew,Carlee Moser,Eunice Yeh,David A. Wohl,Eric S. Daar,Justin Ritz,Arzhang Cyrus Javan,Joseph J. Eron,Judith S. Currier,Davey M. Smith,Michael D. Hughes

The Journal of Infectious Diseases（2023）

引用 2|浏览30

关键词

ACTIV-2,COVID-19,internal validity,patient-reported outcomes,symptom diary,symptom outcomes,symptom rebound,symptom recurrence,time to symptom resolution

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要